RHEI to distribute Drs. Hans Schreuder in Asia
This article was originally published in The Rose Sheet
Executive Summary
RHEI Pharmaceuticals has licensed Drs. Hans Schreuder Vision for Health Skin Care line for marketing and distribution in Asia, according to Feb. 21 release. RHEI - a specialty pharmaceuticals company that focuses on marketing proprietary medicines in China - will distribute the line through its pharmacy division. "Professional skin care is one of the fastest-growing segments within the cosmetics and toiletries industry in China. With an increase in Chinese living standards, people are seeking more specialized products and appreciate a holistic approach to healthcare," says Dr. Hans Schreuder, president and founder of the line, which consists of seven skin-nutritious products - including a scar treatment, facial cleansing lotion and anti-aging morning and night creams - featuring natural ingredients such as vitamin E, oatmeal, yeast, lactic acid and soy...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.